{"database": "openregs", "table": "documents", "rows": [["DEA-2022-0001-0591", "DEA", "DEA-2022-0001", "Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DiPT), 5-methoxy-alpha-methyltryptamine (5-MeO-AMT), 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT), 5-methoxy-N,N-diethyltryptamine (5-MeO-DET), and N,N-diisopropyltryptamine (DiPT) in Schedule I; Withdrawal and Notice of Hearing", "Proposed Rule", null, "2022-07-27T04:00:00Z", 2022, 7, "2022-07-27T04:00:00Z", null, "2022-07-27T12:21:18Z", "2022-16102", 0, 0, "09000064851ecfe2"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["DEA-2022-0001-0591"], "units": {}, "query_ms": 21.46865497343242, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}